Financial Analysis: Sangamo Therapeutics Inc (SGMO)’s Ratios Unveil Key Insights

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

As of close of business last night, Sangamo Therapeutics Inc’s stock clocked out at $2.82, up 6.62% from its previous closing price of $2.64. In other words, the price has increased by $6.62 from its previous closing price. On the day, 7.62 million shares were traded. SGMO stock price reached its highest trading level at $2.84 during the session, while it also had its lowest trading level at $2.54.

Ratios:

To gain a deeper understanding of SGMO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.

On December 10, 2024, H.C. Wainwright reiterated its Buy ratingand also kept the price unchanged to $10.

RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 03, 2023, whereas the target price for the stock was revised from $6 to $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 588384576 and an Enterprise Value of 576058880. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.25 while its Price-to-Book (P/B) ratio in mrq is 15.03. Its current Enterprise Value per Revenue stands at 11.016 whereas that against EBITDA is -4.922.

Stock Price History:

Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 52.59%, while the 200-Day Moving Average is calculated to be 193.82%.

Shares Statistics:

It appears that SGMO traded 7.68M shares on average per day over the past three months and 6279860 shares per day over the past ten days. A total of 208.62M shares are outstanding, with a floating share count of 199.09M. Insiders hold about 4.58% of the company’s shares, while institutions hold 27.00% stake in the company. Shares short for SGMO as of 1732838400 were 14949043 with a Short Ratio of 1.95, compared to 1730332800 on 18978498. Therefore, it implies a Short% of Shares Outstanding of 14949043 and a Short% of Float of 7.21.

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Revenue Estimates

For the next quarter, 7 analysts are estimating revenue of $31.5M. There is a high estimate of $70M for the next quarter, whereas the lowest estimate is $12M.

A total of 6 analysts have provided revenue estimates for SGMO’s current fiscal year. The highest revenue estimate was $67.9M, while the lowest revenue estimate was $51M, resulting in an average revenue estimate of $59.15M. In the same quarter a year ago, actual revenue was $176.23MBased on 7 analysts’ estimates, the company’s revenue will be $96.49M in the next fiscal year. The high estimate is $274M and the low estimate is $20.84M.

Most Popular